Obesity trials recruiting in New York

All Obesity trials nationally

Cities in New York

Recruiting trials in New York

• A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
  NCT05963971 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 21 Years · Sex: All (male and female) · New York: New York
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
  NCT07351045 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Buffalo
• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
  NCT06143956 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Amherst, East Syracuse, Port Jefferson Station, Rochester
• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Laurelton, Long Island City
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
  NCT06672549 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · New York: Buffalo
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
  NCT07639021 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Westfield
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany
• A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07481630 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Westfield
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
  NCT07253285 · Phase: Phase 3 · Ages: 8 Years to 18 Years · Sex: All (male and female) · New York: Buffalo, Syracuse, The Bronx
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: West Seneca
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Brooklyn, New York, Rochester
• A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
  NCT07654374 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · New York: Albany, Brooklyn, The Bronx
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
  NCT07282600 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Long Island City
• A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
  NCT07321886 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
  NCT07369011 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Buffalo
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
  NCT07392190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
  NCT06897475 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Long Island City, Staten Island, West Seneca
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
  NCT07743450 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: East Northport, East Syracuse, New Windsor
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
  NCT07743463 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New Windsor
• A Study of Pitolisant in Patients With Prader-Willi Syndrome
  NCT06366464 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · New York: Brooklyn, The Bronx
• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
  NCT06439277 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · New York: Buffalo, Syracuse
• A Study of a Weight Loss Intervention in People With Endometrial Cancer
  NCT06751589 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Female · New York: Commack, Harrison, New York, Uniondale
• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
  NCT07784725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Cortland
• A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
  NCT07446439 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York, Syosset
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
  NCT06864026 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
  NCT07589608 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Amherst, Rochester
• A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program
  NCT05748158 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 59 Years · Sex: All (male and female) · New York: New York
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
  NCT07595549 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, Rochester
• A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
  NCT06760546 · Phase: Phase 3 · Ages: 4 Years and older · Sex: All (male and female) · New York: New York
• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
  NCT07339423 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: West Seneca
• AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
  NCT07571005 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
  NCT07571109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07509307 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Alpelisib Challenge Test (ACT)
  NCT07778524 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: New York
• Atomoxetine in Melanocortin Obesity Syndrome
  NCT06899178 · Phase: Phase 2 · Ages: 6 Years and older · Sex: All (male and female) · New York: New York
• Blood Collection Biorepository for Liver Disease Research
  NCT03025074 · Phase: Not specified · Ages: 7 Years and older · Sex: All (male and female) · New York: Buffalo
• Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
  NCT07356310 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• CHIME: Comparing Health Interventions for Maternal Equity
  NCT06724172 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: Flushing, New York
• Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults
  NCT06795386 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York
• Circadian Misalignment and Energy Balance
  NCT03663530 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 49 Years · Sex: All (male and female) · New York: New York
• Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder
  NCT07212673 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: The Bronx
• Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
  NCT07090005 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 65 Years · Sex: All (male and female) · New York: New York
• Developmental Trajectories of Reinforcer Pathology and Childhood Obesity
  NCT07229508 · Phase: Not specified · Ages: 8 Years to 11 Years · Sex: All (male and female) · New York: Buffalo
• Effect of Insulin Lowering on Lipogenesis
  NCT07403604 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Effects of HIIT vs. TRE on Type 2 Diabetes Risk
  NCT07215533 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 30 Years · Sex: All (male and female) · New York: Syracuse
• Effects of Ultra Processed Food on Intestinal Energy Harvest
  NCT06853288 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years and older · Sex: All (male and female) · New York: New York
• Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
  NCT07654361 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · New York: Albany, Brooklyn
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn, Buffalo, Long Island City, Rochester
• Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
  NCT07284979 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany
• Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
  NCT07284901 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Albany, Laurelton, New York
• Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
  NCT07284875 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Rochester
• Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
  NCT07575399 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: New York, Rochester
• Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
  NCT04494048 · Phase: Not specified · Ages: 18 Years to 89 Years · Sex: All (male and female) · New York: New York
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female) · New York: Binghamton, Poughkeepsie, Rochester, Saratoga Springs
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
  NCT07684235 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: Binghamton, Rochester
• Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
  NCT07144800 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Food FARMacia: Reducing Childhood Obesity in Households With Food Insecurity
  NCT06051591 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Months and older · Sex: All (male and female) · New York: New York
• Graded Insulin Suppression Test P&F
  NCT06592261 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• HIIT Effects on Cardiometabolic Health
  NCT05838950 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 25 Years · Sex: All (male and female) · New York: Syracuse
• High Fructose Diet, the Gut Microbiome, and Metabolic Health
  NCT06329544 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 45 Years · Sex: All (male and female) · New York: New York
• Human Models of Selective Insulin Resistance: Alpelisib, Part I
  NCT06354088 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: New York
• Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
  NCT07641361 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · New York: Buffalo
• Impact of Bright Light Therapy on Prader-Willi Syndrome
  NCT05939453 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 88 Years · Sex: All (male and female) · New York: Brooklyn
• Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
  NCT07217756 · Phase: Not specified · Ages: 12 Years to 18 Years · Sex: All (male and female) · New York: Rochester
• Impact of Yo-Yo Sleep on Cardiometabolic Health
  NCT05880758 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 49 Years · Sex: All (male and female) · New York: New York
• In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
  NCT06557317 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: Female · New York: Brooklyn
• Incretin Therapies in Obesity-related HFpEF
  NCT07554638 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · New York: New York
• International Weight Control Registry
  NCT04907396 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: West Point
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
  NCT07226765 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: Laurelton
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
  NCT07225686 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: Laurelton
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · New York: Albany, New York, Poughkeepsie, Staten Island
• Maternal Smoking Cessation and Pediatric Obesity Prevention
  NCT03514602 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 39 Years · Sex: Female · New York: Buffalo
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: New York, Yonkers
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · New York: New York, Yonkers
• Mothers' Action Project for Child Health
  NCT06753669 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Months to 45 Years · Sex: All (male and female) · New York: New York
• Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
  NCT07106879 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn
• Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
  NCT03880422 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · New York: Buffalo
• Physical Activity: Feasibility Study
  NCT05935111 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · New York: Binghamton
• Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
  NCT07446998 · Phase: Phase 2 · Ages: 65 Years to 100 Years · Sex: All (male and female) · New York: New York
• RESET System Pivotal Trial (Rev F)
  NCT04101669 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 65 Years · Sex: All (male and female) · New York: New York
• Reducing Obesity Using Social Ties Program
  NCT06335810 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCT
  NCT07254065 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · New York: New Hyde Park
• Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.
  NCT01998750 · Phase: Not specified · Ages: Up to 80 Years · Sex: All (male and female) · New York: New York
• Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
  NCT05770570 · Phase: Phase 2 · Ages: 21 Years and older · Sex: All (male and female) · New York: New York
• The Precision Nutrition New York Study
  NCT06777498 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 50 Years · Sex: All (male and female) · New York: Ithaca
• Time Restricted Eating for WeIght LoSs MainTenance-2
  NCT07190170 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 65 Years · Sex: All (male and female) · New York: New York
• Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
  NCT07257484 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · New York: New York
• Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
  NCT06412536 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn
• Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
  NCT05919797 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York
• Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
  NCT02602769 · Phase: Not specified · Ages: 2 Years to 20 Years · Sex: All (male and female) · New York: Boston, New York